Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial.

Goebel A, Baranowski A, Maurer K, Ghiai A, McCabe C, Ambler G.

Ann Intern Med. 2010 Feb 2;152(3):152-8. doi: 10.7326/0003-4819-152-3-201002020-00006.

PMID:
20124231
2.

Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial.

Goebel A, Shenker N, Padfield N, Shoukrey K, McCabe C, Serpell M, Sanders M, Murphy C, Ejibe A, Milligan H, Kelly J, Ambler G.

Trials. 2014 Oct 24;15:404. doi: 10.1186/1745-6215-15-404.

3.

Favorable outcome of an acute complex regional pain syndrome with immunoglobulin infusions.

Medlin F, Zekeridou A, Renaud S, Kuntzer T.

Clin J Pain. 2013 Nov;29(11):e33-4. doi: 10.1097/AJP.0b013e318292189e.

PMID:
24104048
4.

Plasma Exchange Therapy in Patients with Complex Regional Pain Syndrome.

Aradillas E, Schwartzman RJ, Grothusen JR, Goebel A, Alexander GM.

Pain Physician. 2015 Jul-Aug;18(4):383-94.

5.

A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.

Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S, Glovsky M, Stiehm R, Stocks J, Rosenberg L, Shames RS, Corn B, Shearer WT, Bacot B, DiMaio M, Tonetta S, Adelman DC.

Clin Immunol. 1999 May;91(2):126-33.

PMID:
10227804
6.

Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors.

Dubuis E, Thompson V, Leite MI, Blaes F, Maihöfner C, Greensmith D, Vincent A, Shenker N, Kuttikat A, Leuwer M, Goebel A.

Pain. 2014 Nov;155(11):2408-17. doi: 10.1016/j.pain.2014.09.022. Epub 2014 Sep 22.

PMID:
25250722
7.

Short-term treatment with parecoxib for complex regional pain syndrome: a randomized, placebo-controlled double-blind trial.

Breuer AJ, Mainka T, Hansel N, Maier C, Krumova EK.

Pain Physician. 2014 Mar-Apr;17(2):127-37.

8.

An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.

Arnold DF, Burton J, Shine B, Wojnarowska F, Misbah SA.

Br J Dermatol. 2009 May;160(5):1098-102. doi: 10.1111/j.1365-2133.2009.09034.x. Epub 2009 Feb 16.

PMID:
19222460
9.

Bier block with methylprednisolone and lidocaine in CRPS type I: a randomized, double-blinded, placebo-controlled study.

Taskaynatan MA, Ozgul A, Tan AK, Dincer K, Kalyon TA.

Reg Anesth Pain Med. 2004 Sep-Oct;29(5):408-12.

PMID:
15372383
10.

Immunoglobulin responsive chronic pain.

Goebel A.

J Clin Immunol. 2010 May;30 Suppl 1:S103-8. doi: 10.1007/s10875-010-9403-8. Review.

PMID:
20424897
11.

Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study.

Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M.

Pain. 2009 Dec 15;147(1-3):107-15. doi: 10.1016/j.pain.2009.08.015. Epub 2009 Sep 23.

PMID:
19783371
12.

A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.

Hahn AF, Beydoun SR, Lawson V; IVIG in MMN Study Team, Oh M, Empson VG, Leibl H, Ngo LY, Gelmont D, Koski CL.

J Peripher Nerv Syst. 2013 Dec;18(4):321-30. doi: 10.1111/jns5.12046.

PMID:
24725024
13.

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE.

Neurology. 2000 Nov 14;55(9):1256-62.

PMID:
11087764
14.

A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy.

Comi G, Roveri L, Swan A, Willison H, Bojar M, Illa I, Karageorgiou C, Nobile-Orazio E, van den Bergh P, Swan T, Hughes R, Aubry J, Baumann N, Hadden R, Lunn M, Knapp M, Léger JM, Bouche P, Mazanec R, Meucci N, van der Meché F, Toyka K; Inflammatory Neuropathy Cause and Treatment Group.

J Neurol. 2002 Oct;249(10):1370-7.

PMID:
12382151
15.
16.

Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.

Gajdos P, Tranchant C, Clair B, Bolgert F, Eymard B, Stojkovic T, Attarian S, Chevret S; Myasthenia Gravis Clinical Study Group.

Arch Neurol. 2005 Nov;62(11):1689-93.

PMID:
16286541
17.

Intrathecal glycine for pain and dystonia in complex regional pain syndrome.

Munts AG, van der Plas AA, Voormolen JH, Marinus J, Teepe-Twiss IM, Onkenhout W, van Gerven JM, van Hilten JJ.

Pain. 2009 Nov;146(1-2):199-204. doi: 10.1016/j.pain.2009.07.030. Epub 2009 Aug 14.

PMID:
19683392
18.

Intravenous regional ketorolac and lidocaine in the treatment of complex regional pain syndrome of the lower extremity: a randomized, double-blinded, crossover study.

Eckmann MS, Ramamurthy S, Griffin JG.

Clin J Pain. 2011 Mar-Apr;27(3):203-6. doi: 10.1097/AJP.0b013e3181fd5150.

PMID:
21358290
20.

Intravenous immunoglobulin for myasthenia gravis.

Gajdos P, Chevret S, Toyka K.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002277. doi: 10.1002/14651858.CD002277.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD002277.

PMID:
18254004

Supplemental Content

Support Center